Site #107 — Marietta, Georgia

Site #107 is a clinical research site located in Marietta, Georgia, United States 30060.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #107 has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Marietta

Browse all research sites in Georgia · View every site in Marietta

• Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
• WellStar Health System-Kennestone Hospital
• Northside Hospital, Inc. GCS/Kennestone
• Wellstar Hospitals
• WellStar Cobb Hospital, WellStar Kennestone Hospital
• Wellstar Hospital
• Northside Hospital, Inc.-Georgia Cancer Specialists
• Wellstar Kennestone Hospital
• Northside Hospital
• Life University
• Kennestone Cancer Center at Wellstar Kennestone Hospital
• Northside Hospital, Inc. - GCS/Marietta

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #107?

Site #107 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #107 conducted?

Site #107 has 1 clinical trials on record. Their work covers Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is Site #107 accredited by Crixeo Clinical Trials?

Site #107 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #107?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.